Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Immucell (ICCC) Non-cash Items (2018 - 2025)

Historic Non-cash Items for Immucell (ICCC) over the last 8 years, with Q3 2025 value amounting to $717859.0.

  • Immucell's Non-cash Items rose 13795.34% to $717859.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $717859.0, marking a year-over-year increase of 13795.34%. This contributed to the annual value of -$870558.0 for FY2024, which is 1872.46% up from last year.
  • Latest data reveals that Immucell reported Non-cash Items of $717859.0 as of Q3 2025, which was up 13795.34% from $514375.0 recorded in Q2 2025.
  • Immucell's 5-year Non-cash Items high stood at $1.3 million for Q1 2021, and its period low was -$1.9 million during Q3 2024.
  • For the 5-year period, Immucell's Non-cash Items averaged around -$175718.2, with its median value being -$661310.0 (2022).
  • Per our database at Business Quant, Immucell's Non-cash Items surged by 72904.39% in 2021 and then crashed by 81693.61% in 2023.
  • Immucell's Non-cash Items (Quarter) stood at $468425.0 in 2021, then crashed by 241.18% to -$661310.0 in 2022, then plummeted by 61.97% to -$1.1 million in 2023, then grew by 18.72% to -$870558.0 in 2024, then soared by 182.46% to $717859.0 in 2025.
  • Its Non-cash Items stands at $717859.0 for Q3 2025, versus $514375.0 for Q2 2025 and -$1.1 million for Q1 2025.